Pharmacological Chaperones in Nephrogenic Diabetes Insipidus: Possibilities for Clinical Application

ISSN： 1173-8804

Source： BioDrugs, Vol.21, Iss.3, 2007-01, pp. : 157-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Persistent phenotypic correction of central diabetes insipidus using adeno-associated virus vector expressing Arginine-Vasopressin in brattleboro rats

By Ideno J. Mizukami H. Honda K. Okada T. Hanazono Y. Kume A. Saito T. Ishibashi S. Ozawa K.

Molecular Therapy, Vol. 8, Iss. 6, 2003-12 ,pp. : 895-902

Elsevier

Access to resources Recommend Favorite

Coxsackie B Virus Infection in Idiopathic Dilated Cardiomyopathy: Clinical and Pharmacological Implications

By Fujioka S. Kitaura Y.

BioDrugs, Vol. 15, Iss. 12, 2001-01 ,pp. : 791-799

Adis International

Access to resources Recommend Favorite

Colloidal and Pharmacological Activity of Albumin in Clinical Fluid Management:Recent Developments

Current Drug Therapy, Vol. 1, Iss. 3, 2006-01 ,pp. : 319-328

Bentham Science Publishers

Access to resources Recommend Favorite

Stress and molecular chaperones in disease

By Macario A.

International Journal of Clinical & Laboratory Research, Vol. 30, Iss. 2, 2000-06 ,pp. : 49-66

Springer Publishing Company

Access to resources Recommend Favorite

Gene and Cell Therapies for Diabetes Mellitus: Strategies and Clinical Potential

By Giannoukakis N.

BioDrugs, Vol. 16, Iss. 3, 2002-01 ,pp. : 149-173

Adis International

Access to resources Recommend Favorite